Litcius/Paper detail

Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study

Jun Hwa Hong, Jun Sung Moon, Kayeon Seong, Soo Lim

2023Diabetes Research and Clinical Practice10 citationsDOI

Topics & Concepts

DapagliflozinSitagliptinMedicineMetforminSulfonylureaType 2 diabetesInternal medicineDiabetes mellitusUrologyEndocrinologyInsulinGastroenterologyDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study | Litcius